Ethan Korngold: I’m Excited by The New CREST-2 Trial Data Presented at SVIN2025, VEITH2025 and Published in NEJM
Ethan Korngold, Chief Medical Officer and DVP of Medical Affairs for the Abbott Vascular Business Unit, shared on LinkedIn:
”I’m excited by the new CREST-2 trial data presented at SVIN2025, VEITH2025 and published in NEJM adding an important chapter to understanding stroke prevention in patients with high-grade asymptomatic carotid stenosis.
In the stenting trial, carotid artery stenting (CAS) added to intensive medical therapy was associated with 2.8% stroke and death out to 4-years vs 6.0% for medical therapy.
The absolute difference of 3.2% favoring CAS was significant.
We are proud of the role our market leading carotid technologies including Xact and Emboshield NAV6, have in advancing research in stroke prevention.
These results will encourage the field to re-examine long-held assumptions about asymptomatic disease management.
As new evidence emerges, our responsibility is to interpret it carefully, understand where it applies, and continue refining strategies that support long-term patient outcomes.
My gratitude to the CREST-2 investigators for their commitment to a rigorous comparative study.
Read the abstract in NEJM.
Stay updated with Hemostasis Today.
-
May 28, 2026, 05:29Kidist K.: First Balloon Pulmonary Angioplasty Performed as New CTEPH Program Launches
-
May 28, 2026, 04:59Maria Sol Andres: Exploring Lipid Disorders in Modern Cancer Care
-
May 28, 2026, 04:42Francesca Granata: Representing the Porphyria Community at the 79th World Health Assembly
-
May 28, 2026, 04:29Samone Cook: When Collaboration Turns Into Organizational Coagulation
-
May 28, 2026, 03:42Lara Bloom: 15,000 Steps, Countless Conversations – One Unforgettable WHA79
-
May 27, 2026, 23:00Octavio Marques Pontes-Neto: Exchanging Latin American Experiences at the Global Stroke Alliance Meeting in Buenos Aires
-
May 27, 2026, 17:51Nita Radhakrishnan: Post Graduate Institute of Child Health Receives WFH Data Quality Certification for Excellence
-
May 27, 2026, 17:51Fiona Robinson: What exactly Are Rebalancing Agents for Bleeding Aisorders?
-
May 27, 2026, 17:14Khurram Nasir: Can Earlier LDL-C Lowering Change the Trajectory of Cardiovascular Disease?